Is Adeshwar Meditex overvalued or undervalued?

As of 1 October 2025, Adeshwar Meditex has moved from a fair to an attractive valuation grade. The company is currently considered undervalued, with a PE ratio of 11.29, an EV to EBITDA ratio of 7.56, and a Price to Book Value of 0.63. These ratios indicate that the company is trading at a significant discount compared to its peers, such as Poly Medicure, which has a PE ratio of 55.34, and Blue Jet Health, with a PE ratio of 32.02.
In comparison to its industry, Adeshwar Meditex's valuation metrics suggest a strong potential for growth, especially given its attractive EV to EBIT ratio of 8.53. While the stock has underperformed the Sensex over the past year with a return of -37.45% compared to the Sensex's -3.90%, the current valuation presents an opportunity for investors looking for value in the healthcare services sector.